Search Browse Earnings

Cellectar Biosciences, Inc. — SlamSEC

Cellectar Biosciences, Inc.

Nasdaq:CLRB

Pharmaceutical Preparations·FLORHAM PARK, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$51.5M

FY 2025

Net Income

-$44.6M

FY 2025

EPS (Diluted)

-$41.89

FY 2025

Stock Price

$2.75

-0.7%

2026-03-09

52W Range

$2.45 – $20.59

P/E Ratio

-0.1x

Market Cap

$11.7M

Cash

$23.3M

FY 2025

Total Debt

$416,813

FY 2015

Net Cash

$22.9M

FY 2015

Enterprise Value

-$11.2M

Debt / EBITDA

0.4x

FY 2025

EV / EBITDA

0.2x

Employees

—

CEO

Caruso James V

CFO

Kolean Chad J